PerFECT – Pertuzumab in First Line Treatment of HER2-positive metastatic breast Cancer patients: A cohort study of patients treated either with docetaxel and Trastuzumab or docetaxel, trastuzumab and pertuzumab

Authors :: Lothar Häberle
Andreas Schneeweiss
Sara Y. Brucker
Erik Belleville
PA Fasching
Tanja Fehm
T Spall
Hans Tesch
Sven Becker
Source :: Senologie - Zeitschrift für Mammadiagnostik und -therapie. 13
Publication Year :: 2016
Publisher :: Georg Thieme Verlag KG, 2016.

Subjects :: Oncology
medicine.medical_specialty
business.industry
medicine.disease
Metastatic breast cancer
First line treatment
Docetaxel/trastuzumab
Docetaxel
Trastuzumab
Internal medicine
medicine
Pertuzumab
business
medicine.drug
Cohort study

Tools